Cargando…

Expedited approval system for regenerative medicine products – Is it unusual?

Detalles Bibliográficos
Autores principales:	Yano, Kazuo, Watanabe, Natsumi, Yamato, Masayuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society for Regenerative Medicine 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581845/ https://www.ncbi.nlm.nih.gov/pubmed/31245490 http://dx.doi.org/10.1016/j.reth.2016.05.001

Ejemplares similares

Comparison of the new Japanese legislation for expedited approval of regenerative medicine products with the existing systems in the USA and European Union
por: Jokura, Yoji, et al.
Publicado: (2017)

PRP therapy classification
por: Yamato, Masayuki, et al.
Publicado: (2015)

Bayesian statistics and clinical trial designs for human cells and tissue products for regulatory approval
por: Jokura, Yoji, et al.
Publicado: (2016)

Re-examination of regulatory opinions in Europe: possible contribution for the approval of the first gene therapy product Glybera
por: Watanabe, Natsumi, et al.
Publicado: (2015)

Regulatory approval for autologous human cells and tissue products in the United States, the European Union, and Japan
por: Yano, Kazuo, et al.
Publicado: (2014)

Regenerative medicine for esophageal reconstruction after cancer treatment
por: Yamato, Masayuki, et al.
Publicado: (2015)

Compassionate use and hospital exemption for regenerative medicine: Something wrong to apply the program for patients in a real world
por: Yano, Kazuo, et al.
Publicado: (2018)

Non-clinical assessment design of autologous chondrocyte implantation products
por: Ikawa, Taisuke, et al.
Publicado: (2015)

Expedited regulatory product approval in the time of COVID-19
por: Novack, Gary D.
Publicado: (2022)

The Potential Benefit of Expedited Development and Approval Programs in Precision Medicine
por: Kantor, Ariel, et al.
Publicado: (2021)

Regenerative Medicine in the State of Florida: Letter Outlining the Florida Organization for Regenerative Medicine
por: Bruce, Charles J., et al.
Publicado: (2018)

Use of Expedited Regulatory Programs and Clinical Development Times for FDA-Approved Novel Therapeutics
por: Wong, Alissa K., et al.
Publicado: (2023)

Compassionate use of drugs and medical devices in the United States, the European Union and Japan
por: Tsuyuki, Kenichiro, et al.
Publicado: (2016)

Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan
por: Nagai, Sumimasa
Publicado: (2019)

Preface of the special issue: Regenerative medicine of the digestive tract
por: Yamato, Masayuki, et al.
Publicado: (2020)

Pelvic Organ Prolapse: The Regenerative Medicine Approach
por: Karon, Magdalene
Publicado: (2019)

Expedited Development Programs at the Food and Drug Administration: Insights and Opportunities
por: Collins, Grace, et al.
Publicado: (2021)

Ethics Approval
por: Ross, W M
Publicado: (1994)

Fibrin‐targeting delivery: a novel platform for cardiac regenerative medicine
por: Huang, Zheyong, et al.
Publicado: (2016)

Comparing cancer drug approval systems in the United States and Japan
por: Kaneda, Yudai, et al.
Publicado: (2023)

The approval of revised diagnostic criteria for DIC from the Japanese Society on Thrombosis and Hemostasis
por: Wada, Hideo, et al.
Publicado: (2017)

FDA expedited approval and implications for rational formulary and health plan design
por: Ferries, Erin A, et al.
Publicado: (2021)

Conditional Approval Pathways: The “Special” Case of Global Regenerative Medicine Regulation
por: Smith, James A., et al.
Publicado: (2017)

4th William S Hancock award in regulatory science
por: Yamato, Masayuki
Publicado: (2015)

Re: “The next phase of human gene-therapy oversight”
por: Yamato, Masayuki
Publicado: (2019)

A cage cleaning method for researchers without a cage-washing machine or cage-washing staff
por: Sasaki, Ryo, et al.
Publicado: (2019)

Association between FDA and EMA expedited approval programs and therapeutic value of new medicines: retrospective cohort study
por: Hwang, Thomas J, et al.
Publicado: (2020)

Transesophageal Echocardiography Guidance for Expedited Pulmonary Artery Catheter Insertion and Accurate Estimation of Cardiac Output
por: Raut, Monish S, et al.
Publicado: (2018)

Experience of a resident physician in general surgery basic area on board of an expedition in the amazon river
por: MILANI, MARINA FANELLI LUCHIARI, et al.
Publicado: (2022)

Distinct fibroblast progenitor subpopulation expedites regenerative mucosal healing by immunomodulation
por: Ko, Kang I., et al.
Publicado: (2022)

Robert M. Nerem – International expert on mechanobiology, cellular engineering, tissue engineering and regenerative medicine
por: García, Andrés J., et al.
Publicado: (2020)

Regulatory Pathways Supporting Expedited Drug Development and Approval in ICH Member Countries
por: Franco, Pedro, et al.
Publicado: (2022)

FDA approved ready to use phenylephrine
por: Bhatia, Pradeep Kumar, et al.
Publicado: (2021)

Four Food and Drug Administration draft guidance documents and the REGROW Act: A litmus test for future changes in human cell‐ and tissue‐based products regulatory policy in the United States?
por: Yano, Kazuo, et al.
Publicado: (2018)

Letter to the editor: Comment on the Regulatios of the Simplified Registration and Approval Management for Compound Recipe of Classical Prescription of Traditional Chinese Medicine
por: Chen, Shilin, et al.
Publicado: (2018)

The Solvency of Approved Societies
Publicado: (1914)

Expedited approval of cancer drugs without randomized controlled trials: Too good to be true?
por: Shepshelovich, Daniel, et al.
Publicado: (2018)

The use of validated and nonvalidated surrogate endpoints in two European Medicines Agency expedited approval pathways: A cross-sectional study of products authorised 2011–2018
por: Schuster Bruce, Catherine, et al.
Publicado: (2019)

Hospitals and the Approved Societies' Surplus
por: Lamb, S. R.
Publicado: (1921)

Ethics approval for health professions education research: Necessary and beneficial
por: Schutte, Tim, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7239063s50jdnp0gshdjvi75ol